Technical Articles
Selective inhibitor
FGFR4: Why Hepatocellular Carcinoma Targeting Focuses on This Selective Receptor
2026-09-20Among the four FGFR family members, FGFR4 alone resides in the liver and binds the KLB co-receptor. From an industry perspective, this article dissects the FGF19 axis, its association with hepatocellular carcinoma and the design logic of selective in
View details
- Signaling Pathway
- FGFR4
- Hepatocellular carcinoma
- FGF19
- Selective inhibitor
- Targeted therapy
- UA011375
- 1
Link：
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy 
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
Business license (three certificates in one) Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.
